Zevra Therapeutics

Price & Volume

Stats

Open	$10.99
Previous Close	$10.82
Day Range	$10.41-$11.18
52W Range	$6.19-$13.16
Market Cap	$597.2M
Shares Short	7M

Financials

Revenue (12 Mos)	$62M
Revenue Growth (YoY)	481.7%
Gross Profit (12 Mos)	$44.6M
Diluted EPS	-$0.25

News

Yahoo Finance • 5 days ago

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 16 days ago

Zevra Therapeutics rises amid takeover speculation

Yahoo Finance • 23 days ago

Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate)

Yahoo Finance • last month

Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)

About

CEO	Mr. Neil F. McFarlane
CFO	Mr. R. LaDuane Clifton CPA
Address	1180 Celebration Boulevard, Celebration, FL, United States, 34747
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	59